More on the history of arrhythmia in long QT syndrome.
Csanády
Miklós
M
D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000235:genetics; D027682:Cation Transport Proteins / Q000187:drug effects / Q000235:genetics; D004268:DNA-Binding Proteins / Q000187:drug effects / Q000235:genetics; D004232:Diuretics / Q000008:administration & dosage; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels; D006801:Humans; D008133:Long QT Syndrome / Q000188:drug therapy* / Q000235:genetics*; D015221:Potassium Channels / Q000187:drug effects / Q000235:genetics; D024642:Potassium Channels, Voltage-Gated; D011189:Potassium Chloride / Q000008:administration & dosage*; D013148:Spironolactone / Q000008:administration & dosage; D015534:Trans-Activators / Q000187:drug effects / Q000235:genetics; D000071230:Transcriptional Regulator ERG
D027682:Cation Transport Proteins; D004268:DNA-Binding Proteins; D004232:Diuretics; C072312:ERG protein, human; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels; C092509:KCNH6 protein, human; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D015534:Trans-Activators; D000071230:Transcriptional Regulator ERG; D013148:Spironolactone; D011189:Potassium Chloride